We’re proud to share that Dr. Keith Jarvi, MD, FRCSC, has been named the 2026 recipient of the Award of Excellence in Reproductive Medicine by the Canadian Fertility and Andrology Society (CFAS).
At FlowLabs, we’ve seen firsthand the impact of Dr. Jarvi’s contributions extend across multiple fields of urology and infertility, including genomics, prostate cancer, and non-invasive diagnostics. Through his research into TEX101 and seminal plasma biomarkers, key advancements have been made in diagnostic precision and risk stratification for azoospermia.
As project leader on initiatives including Genome Canada’s Prostate Cancer Predict, Dr. Jarvi continues to connect research with clinical applications while advancing the field through mentorship and collaboration.
